Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.24.2.u1
Stock-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2024
Schedule of number of cash-settled RSUs granted

​

​

​

​

​

​

​

​

Six months ended

​

​

​

​

June 30, 2024

​

​

​

​

RSUs Granted (000's)

​

​

​

​

​

​

​

QRTEA time-based RSUs, subsidiary employees (1)

​

20,945

​

​

QRTEA performance-based RSUs, subsidiary employees (2)

​

20,305

​

​

QRTEA performance-based RSUs, Qurate Retail employees (3)

​

921

​

​

(1) Grants mainly vest equally over three years.
(2) Grants vest equally over three years, subject to the satisfaction of certain performance objectives.
(3) Grants vest one year from the month of grant, subject to the satisfaction of certain performance objectives.
Schedule of number and weighted average GDFV of RSUs granted to certain officers, employees and directors

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted

​

​

​

Weighted

​

​

​

Series A

​

Average

​

Series B

​

Average

​

​

​

(000's)

​

GDFV

​

(000's)

​

GDFV

​

RSUs outstanding at January 1, 2024

 

14,691

​

$

3.30

​

353

​

$

5.51

​

Granted

 

3,740

​

$

1.23

​

296

​

$

5.01

​

Vested

 

(5,675)

​

$

3.73

​

(353)

​

$

4.85

​

Forfeited/Cancelled

 

(1,831)

​

$

2.33

​

—

​

$

—

​

RSUs outstanding at June 30, 2024

 

10,925

​

$

2.53

​

296

​

$

5.01

 

Common Class A  
Schedule of number, weighted average exercise price ("WAEP"), Weighted average remaining life and aggregate intrinsic value of the awards

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

​

    

​

​

    

Weighted

    

Aggregate

 

​

​

​

​

​

​

​

average

​

intrinsic

​

​

​

Series A

​

​

​

​

remaining

​

value

​

​

​

(000's)

​

WAEP

​

life

​

(millions)

​

Options outstanding at January 1, 2024

 

23,530

​

$

7.72

​

​

​

​

​

​

​

Granted

 

—

​

$

—

​

​

​

​

​

​

​

Exercised

 

—

​

$

—

​

​

​

​

​

​

​

Forfeited/Cancelled

 

(3,203)

​

$

10.62

​

​

​

​

​

​

​

Options outstanding at June 30, 2024

 

20,327

​

$

7.26

 

2.3

years

​

$

—

​

Options exercisable at June 30, 2024

 

18,020

​

$

7.10

 

2.1

years

​

$

—

​

Common Class B  
Schedule of number, weighted average exercise price ("WAEP"), Weighted average remaining life and aggregate intrinsic value of the awards

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

    

​

    

​

​

    

Weighted

    

Aggregate

 

​

​

​

​

​

​

​

average

​

intrinsic

​

​

​

Series B

​

​

​

​

remaining

​

value

​

​

​

(000's)

​

WAEP

​

life

​

(millions)

​

Options outstanding at January 1, 2024

 

723

​

$

12.35

​

​

​

​

​

​

​

Granted

 

—

​

$

—

​

​

​

​

​

​

​

Exercised

 

—

​

$

—

​

​

​

​

​

​

​

Forfeited/Cancelled

​

(316)

​

$

11.59

​

​

​

​

​

​

​

Options outstanding at June 30, 2024

 

407

​

$

12.95

 

0.8

years

​

$

—

​

Options exercisable at June 30, 2024

 

407

​

$

12.95

 

0.8

years

​

$

—

​

​

​